Health Care

Overview

Health care providers are on the front lines fighting the COVID-19 pandemic. Our health care working group is closely following legal and regulatory developments on COVID-19 and assisting clients in understanding and addressing these issues.

Health Care

Overview

Contact

Partner

Counsel

Associate

Insights

Insights

COVID-19 Weekly Newsletter: Vaccine Update, New Tests and Tracing Efforts

Health Care Amid and After COVID-19: Public Policy Outlook

Evolving Physician Arrangements in a Post-COVID-19 Environment

Online Platform Scrutiny Continues as Congress Reviews Section 230

Federal Telehealth Regulations in the COVID-19 Era

Senate Republicans Introduce COVID-19 Relief Proposals: How Does It Compare to Democrats’ Priorities?

New Jersey Executive Order and Subsequent Guidance Permitting Elective Surgeries and Invasive Procedures to Resume

FDA Amends Imported Non-NIOSH Approved Respirator EUA

FDA Revises EUA Criteria for Respirators Manufactured in China

FDA Revises Enforcement Policy for Face Masks and Respirators

Four-Month Pilot Aims to Address Illegal Online Opioid Sales

FEMA Relief for Hospitals and Health Systems: What’s Covered and How to Apply

Regulatory Actions Impacting Health Insurers and Managed Care Companies in Response to COVID-19

CMS Innovation Center Announces Policies to Address COVID-19

New Jersey Authorizes Pharmacists to Perform COVID-19 Testing

Orders and Guidelines for Resuming Non-Emergent Health Care Procedures in Illinois, New Jersey and Pennsylvania

Global COVID-19 Threats Persist as Online Fraud and Theft Continue

FDA Issues EUA to Increase Availability of Non-Surgical Gowns and Other Apparel

What Health Insurers Should Consider Before Implementing a Premium Discount

HHS Extends Attestation Deadline, Releases Additional General Distribution FAQs and Issues Payment Allocation Methodology Guidance for High Impact Rural Hospital and Provider Payments

How Washington’s Response to COVID-19 Impacts Pharmacy Practice

FDA Revises EUA Criteria for Respirators Manufactured in China

The COVID-19 Epidemic As A Catalyst For Health Care Fraud

HHS Issues Guidance on COVID-19 Uninsured Reimbursements

HHS Begins Distribution of Provider Relief Funds to Hospitals With High COVID-19 Admissions and to Rural Providers

How HIPAA Impacts Provider Disclosure of COVID-19 Testing to Employers

HHS Announces Additional Details Regarding $50 Billion Provider Relief Fund General Distribution

Tracking Telehealth Policies Implemented During the COVID-19 Public Health Emergency

CMS Issues Explanatory Guidance Regarding Stark Blanket Waivers

Amid COVID-19, Internet Intermediaries Can – and Should – Combat Fraud and Harms

A Compilation of Updated CMS and CDC Guidance for Dialysis Facilities in Light of COVID-19

CMS Releases Guidance for Resuming Non-Emergent Procedures

Testing Employees for COVID-19: Responses to FAQs From Employers

CARES Act Relief Fund Payments to Health Care Providers: Key Requirements and Compliance Risks

FDA Grants EUA for General Purpose Face Masks and Continues to Address PPE Shortage

HHS Announces Over $40 Billion in Additional Distributions From the Provider Relief Fund

New Low-Cost Ventilator Approved by FDA for Emergency Use

To Address Mental Health Amid COVID-19, FDA Looks Digital

Megan Herber Comments on CMS Expansion of Telehealth Accessibility

COVID-19 Testing: What Pharmacies Need to Know and How to Minimize Exposure

HHS Issues Advisory Opinion on PREP Act Declaration Immunity

The Elimination of Kickbacks in Recovery Act and COVID-19: Clinical Laboratory Compliance With EKRA in Current Pandemic

Another Step in Expanding Personal Protective Equipment: FDA Extends EUA to Face Shields

Megan Herber Quoted by InsideHealthPolicy on Telehealth During COVID-19

CARES Act: Revisions to the Treatment of Substance Use Disorder (SUD) Records

FDA Expands Use of Certain Non-Cleared Electronic Thermometers During COVID-19 Public Health Emergency

FDA Issues Guidance Regarding Modifications to Certain Cleared Infusion Pumps During COVID-19 Public Health Emergency

Liability Protections for Health Care Workers in an Emergency

New Jersey Removes Barriers to Assistance by Health Care Professionals

FDA Opens Door to Respirators From Chinese Manufacturers, Revises Respirator Enforcement Policy

The CARES Act: Relief for Health Care Providers

FCC Launches Telehealth Initiatives for COVID-19 (and Beyond): Guidance for Health Care Providers

OCR Enforcement Discretion Allows Business Associates to Disclose PHI for Public Health Purposes

CMS’ Blanket Waivers to the Stark Law Offer Relief to Providers During COVID-19 Emergency

FDA Eases Regulations on Face Masks and Respirators During COVID-19 Pandemic

CMS Offers Guidance on Expedited CLIA Certification

New Jersey Expands Access to Telehealth Services During COVID-19

FDA Issues Emergency Use Authorization for Ventilators, Tubing Connectors and Accessories

OCR Issues COVID-19 Information-Sharing Guidance for First Responders

Congress Nears Passage of $2 Trillion COVID-19 Relief Package

CMS Allows for Temporary Medicare Provider Enrollment During COVID-19 Emergency

HHS PREP Act Declaration Offers Broad-Based Tort Immunity to Those Involved in COVID-19 Fight

Payor Policy and Payment Changes Targeting COVID-19

CMS Screening Guidelines in Hospitals and Hospice Agencies

FCC Clarifies Application of TCPA’s ‘Emergency Purposes Exception’ Amid COVID-19 Pandemic

Governor Pritzker Expands Access to Telehealth Services in Illinois

Infection Control Guidance in a Time of Scarcity

Responses to the Current Ventilator Shortage: FDA’s Recommendations and Guidance for Industry and Health Care Providers

COVID-19, Section 1135 Waivers and the Stark Law

Coronavirus: NHS Needs U.K. Manufacturers’ Assistance to Make Ventilators

New Legislation Increases N95 Face Mask Supply for U.S. Health Care Workers

Centers for Medicare & Medicaid Services Issue Guidance Regarding EMTALA Requirements During COVID-19